Tokyo, Japan – May 7, 2026 – Japan’s ambitious national target of achieving 60% lung cancer screening coverage by 2028 appears increasingly challenging, with a new study projecting that most prefectures will fall short of this crucial health objective. The research, published today in the journal Cancers, highlights significant and persistent disparities in screening participation across regions and between genders, underscoring the need for urgent policy interventions and strategic reforms to bolster early detection efforts.
Lung cancer remains a formidable public health concern in Japan, ranking as a leading cause of both cancer incidence and mortality. The national health promotion movement, "Health Japan 21," has set a clear mandate to enhance cancer screening uptake, with a specific goal for lung cancer screening to reach 60% coverage by 2028. However, the latest analysis, leveraging national survey data from 2013 to 2022, paints a stark picture: current trends suggest this target will be missed by a significant margin.
A Decade of Stagnation and Uneven Progress
The study, conducted by researchers from prominent Japanese institutions including Hitotsubashi University and the National Cancer Center, analyzed lung cancer screening participation rates among adults aged 40 to 69. The data, drawn from the Comprehensive Survey of Living Conditions (CSLC), revealed that national screening coverage, while increasing from 42.3% in 2013 to 49.7% in 2022, has not accelerated sufficiently to meet the 2028 benchmark.
"The momentum generated by the initial policy reforms in the early 2010s appears to have stalled," stated Dr. Phuong The Nguyen, a lead author of the study. "While there has been an overall increase, the rate of progress since 2013 has slowed considerably, suggesting that the current strategies are not enough to close the remaining gap."
The research employed Bayesian linear regressions to model screening coverage trends and project future uptake. These projections indicate that by 2028, only 11 out of Japan’s 47 prefectures are on track to meet the 60% coverage target. Alarmingly, four prefectures – Kyoto, Kumamoto, Kagoshima, and Okinawa – are projected to be unlikely to reach the goal within the foreseeable future, indicating deep-seated challenges in these regions.
Deep-Rooted Gender and Regional Divides
A critical finding of the study is the persistent and significant gender disparity in screening participation. While national coverage for men stood at 53.2% in 2022, it was only 46.4% for women. This gap translates into a stark difference in the probability of achieving the 60% target: 25.4% for men compared to a mere 7.1% for women nationwide.
"The lower screening participation among women is a serious concern," commented Dr. Hasan Jamil, another key researcher on the project. "While women’s screening rates have been increasing at a faster pace than men’s in recent years, the overall gap remains substantial, and the probability of them reaching the target is significantly lower."
The study attributes some of this disparity to structural factors, including the reliance on workplace-based screening programs that often disproportionately benefit full-time male employees. Women, who are more likely to be in non-regular employment or homemakers, may face greater barriers to accessing these services.
Beyond gender, the research highlights considerable regional variations. The geographic distribution of projected achievement probabilities reveals a concentration of prefectures on track to meet the target in the Tohoku and Chubu regions, while the Kinki and southern Kyushu regions lag furthest behind. This uneven progress suggests that a one-size-fits-all approach to health policy is insufficient for addressing the diverse needs and challenges across Japan.
Examining the Contributing Factors
The study delves into potential reasons behind the persistent screening gaps. The complexity of Japan’s screening delivery system is identified as a significant hurdle. Cancer screening is often fragmented across municipality-based programs, workplace initiatives, and private health check-ups, lacking a unified national framework for data consolidation and outreach. This fragmentation can lead to variable levels of promotion and inconsistent service quality across different providers and regions.
"The decentralized nature of screening provision in Japan, with multiple insurers and employers offering distinct services, complicates coordinated efforts," explained Dr. Takao Suzuki, the senior author. "This lack of integration can impede the centralization of cancer control efforts and contribute to the observed disparities."
Individual factors such as fear of diagnosis, cost, and access also play a role. While smoking cessation campaigns have been effective in reducing smoking rates, particularly among men, the study notes that lung cancer incidence is also rising among never-smoking women, a demographic that may be underserved by current screening strategies.
Official Responses and Future Implications
The findings of this study are expected to prompt a review of current policies by the Ministry of Health, Labour and Welfare (MHLW) and prefectural governments. While the government has established the "Health Japan 21" framework, the research suggests that a re-evaluation of its implementation and the development of more targeted interventions are necessary.
"These projections serve as an early warning," stated Dr. Nguyen. "They highlight where progress is lagging and where stronger, more focused efforts are needed to improve screening uptake and reduce existing inequalities. Without a strategic shift, achieving the national goal by 2028 will be a formidable task."
The study emphasizes the need for policy and system reforms that specifically address prefectures and populations with the lowest participation rates. This could include enhanced public awareness campaigns tailored to specific demographics, improved accessibility of screening facilities in underserved areas, and greater integration of different screening programs to ensure a more equitable and efficient system.
A Call for Renewed Action
The research concludes with a strong call for renewed and intensified policy interventions. The authors suggest that future strategies should consider the unique challenges faced by different regions and genders, potentially incorporating technological advancements like AI-driven risk stratification and digital health platforms to support screening uptake and optimize delivery in areas that require the most attention.
"The evidence clearly indicates that current trajectories are insufficient," concluded Dr. Suzuki. "We need a concerted effort involving policymakers, healthcare providers, and researchers to develop and implement innovative strategies that can accelerate progress and ensure that all citizens have equitable access to vital lung cancer screening." The coming years will be critical in determining whether Japan can course-correct and meet its vital public health objectives for lung cancer prevention and early detection.
About the Author
